Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and Above

NCT07354659 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: A zoster mRNA vaccine SYS6017
OTHER: Placebo
BIOLOGICAL: Active Comparator Vaccine

Sponsor

CSPC Megalith Biopharmaceutical Co.,Ltd.